Mohammad Bashashati, MD

Affiliations: 
Physiology and Pharmacology University of Calgary, Calgary, Alberta, Canada 
Google:
"Mohammad Bashashati"
Mean distance: 16.48 (cluster 40)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tarasiuk A, Milad M, Ahmed ST, et al. (2019) Response to lubiprostone in chronic constipation is associated with increased mucus and mucin output: a randomized clinical trial. Journal of Gastrointestinal and Liver Diseases : Jgld. 28: 263-264
Taher M, Ebrahimi Daryani N, Hedayat M, et al. (2017) Association analysis of RAC1 single nucleotide polymorphisms with ulcerative colitis. Clinics and Research in Hepatology and Gastroenterology
Shafieyoun A, Moraveji S, Bashashati M, et al. (2016) Discs Large Homolog 5 (DLG5) Gene Polymorphism and Crohn's Disease: A Meta-Analysis of the Published Studies. Acta Medica Iranica. 54: 289-95
Sarosiek I, Schicho R, Blandon P, et al. (2016) Urinary metabolites as noninvasive biomarkers of gastrointestinal diseases: A clinical review. World Journal of Gastrointestinal Oncology. 8: 459-65
Bashashati M, Schmulson MJ. (2016) From gene polymorphisms to serum cytokine levels in irritable bowel syndrome. Clinics and Research in Hepatology and Gastroenterology
Bashashati M, McCallum RW. (2015) Is Interstitial Cells of Cajal‒opathy Present in Gastroparesis? Journal of Neurogastroenterology and Motility. 21: 486-93
Schmulson M, Saps M, Bashashati M. (2015) Abnormal immune regulation in children with irritable bowel syndrome. Revista De Gastroenterología De MéXico. 80: 3-5
Bashashati M, Nasser Y, Keenan CM, et al. (2015) Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. British Journal of Pharmacology. 172: 3099-111
Bashashati M, Habibi HR, Keshavarzian A, et al. (2015) Intestinal microbiota: a regulator of intestinal inflammation and cardiac ischemia? Current Drug Targets. 16: 199-208
Keenan CM, Storr MA, Thakur GA, et al. (2015) AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner. British Journal of Pharmacology. 172: 2406-18
See more...